Evidence map›Paper›PMID 40883086›Full record

ArticleJACC. Case reports2025

Salvage of Infected Cardiac Implantable Electronic Device and Pregnancy Preservation Using CITA-MIS.

Moris Topaz, Anna Mazo, Ofer Havakuk, Michal Dekel, Itamar Loewenstein, Haya Fisher, Raphael Rosso, Sami Viskin, Ehud Chorin

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Moris TopazDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Anna MazoDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ofer HavakukDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Michal DekelDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Itamar LoewensteinDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Haya FisherDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Raphael RossoDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sami ViskinDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Ehud ChorinDepartment of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Electronic address: udichorin5@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundManaging pocket infections in cardiac implantable electronic devices (CIEDs) during early pregnancy presents significant clinical challenges, as current guidelines mandate complete system extraction. However, extraction carries high maternal-fetal risks, including surgical complications, radiation exposure, and teratogenic effects of systemic antibiotics. CASE SUMMARY: A 29-year-old woman, 5-week pregnant, was referred for a CIED pocket infection with an extruding implantable cardioverter-defibrillator implanted 9 years earlier for idiopathic ventricular fibrillation. Given the risks of extraction and the patient's desire to preserve her pregnancy, a conservative salvage approach integrating controlled in situ-targeted ultrahigh-concentration antibiotic administration with minimally invasive surgery was performed. The procedure involved limited surgical intervention, targeted antibiotic administration, and meticulous shielding to minimize fetal radiation exposure. Antibiotic levels were monitored daily, maintaining a mean vancomycin area under the concentration-time curve over 24 hours to minimum inhibitory concentration ratio of 31.7 (95% CI: 26.9-36.5) μg·hour/mL, ensuring effective infection control while minimizing systemic toxicity. The patient remained infection-free and underwent a successful cesarean delivery of a full-term healthy baby. WHY BEYOND THE GUIDELINES?: Current recommendations advocate complete CIED system removal for pocket infections; however, they do not address early pregnancy, where extraction may entail significant procedural, maternal, and fetal risks that could, in some cases, lead to consideration of pregnancy termination. This case highlights a safe and effective alternative, supporting the need for guideline expansion to include conservative salvage strategies in high-risk patients. TAKE-HOME MESSAGES: Controlled in situ-targeted ultrahigh-concentration antibiotic administration with minimally invasive surgery offers a safe and effective alternative for managing infected CIEDs in pregnancy, avoiding extraction-related risks, and minimizing maternal and fetal harm while maintaining high local antibiotic concentrations with minimal systemic exposure. Integrating area under the concentration-time curve over 24 hours to minimum inhibitory concentration-guided monitoring ensures precise dosing, reinforcing the need to expand guidelines to include conservative salvage options for high-risk patients.

Indexed as

cardiac pacemakercomplicationventricular fibrillation

Identifiers

PMID40883086
PMCPMC12402365

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.